BLOG

Wednesday, July 21, 2021

Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds

The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/3BqGAeH
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...